The role of uropathogenic Escherichia coli virulence factors in the development of urinary tract infection.

Q3 Medicine
Ketema Bizuwork Gebremedhin, Wondwossen Amogne, Haile Alemayehu, Shubhada Bopegamage, Tadesse Eguale
{"title":"The role of uropathogenic <i>Escherichia coli</i> virulence factors in the development of urinary tract infection.","authors":"Ketema Bizuwork Gebremedhin, Wondwossen Amogne, Haile Alemayehu, Shubhada Bopegamage, Tadesse Eguale","doi":"10.25122/jml-2024-0396","DOIUrl":null,"url":null,"abstract":"<p><p>Urinary tract infections (UTIs) are a significant global public health issue, with <i>Escherichia coli (E. coli)</i>, specifically uropathogenic <i>E. coli</i> (UPEC), being the predominant causative agent. UTIs affect millions of people annually, with a particularly high prevalence among women, children, the elderly, and individuals with compromised immunity or structural abnormalities of the urinary tract. UPEC has evolved a suite of specialized virulence factors like adhesins, flagella, capsular polysaccharides, lipopolysaccharide (LPS), outer membrane vesicles (OMVs), toxins, iron acquisition systems, autotransporters (ATs), and unique proteins such as TcpC and OmpT, that facilitate colonization, immune evasion, and disease progression. These factors enable the pathogen to cause both uncomplicated infections, such as cystitis, and more severe outcomes, including pyelonephritis and, in some cases, renal failure. The host defends against infection through mechanisms such as urine flow, urothelial shedding, cytokine release, antimicrobial peptides, and adaptive immunity. Despite advancements in medical care, the burden of UTIs remains high, underscoring the need for continued research into their pathogenesis and prevention.</p>","PeriodicalId":16386,"journal":{"name":"Journal of Medicine and Life","volume":"18 8","pages":"701-709"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467495/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicine and Life","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25122/jml-2024-0396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Urinary tract infections (UTIs) are a significant global public health issue, with Escherichia coli (E. coli), specifically uropathogenic E. coli (UPEC), being the predominant causative agent. UTIs affect millions of people annually, with a particularly high prevalence among women, children, the elderly, and individuals with compromised immunity or structural abnormalities of the urinary tract. UPEC has evolved a suite of specialized virulence factors like adhesins, flagella, capsular polysaccharides, lipopolysaccharide (LPS), outer membrane vesicles (OMVs), toxins, iron acquisition systems, autotransporters (ATs), and unique proteins such as TcpC and OmpT, that facilitate colonization, immune evasion, and disease progression. These factors enable the pathogen to cause both uncomplicated infections, such as cystitis, and more severe outcomes, including pyelonephritis and, in some cases, renal failure. The host defends against infection through mechanisms such as urine flow, urothelial shedding, cytokine release, antimicrobial peptides, and adaptive immunity. Despite advancements in medical care, the burden of UTIs remains high, underscoring the need for continued research into their pathogenesis and prevention.

Abstract Image

Abstract Image

尿路致病性大肠杆菌毒力因子在尿路感染发展中的作用。
尿路感染(uti)是一个重要的全球公共卫生问题,大肠杆菌(E. coli),特别是尿路致病性大肠杆菌(UPEC)是主要的病原体。尿路感染每年影响数百万人,在妇女、儿童、老年人以及免疫力低下或尿路结构异常的人群中发病率特别高。UPEC已经进化出一系列专门的毒力因子,如粘附素、鞭毛、荚膜多糖、脂多糖(LPS)、外膜囊泡(OMVs)、毒素、铁获取系统、自转运蛋白(ATs)和独特的蛋白质,如TcpC和OmpT,促进定植、免疫逃避和疾病进展。这些因素使病原体既能引起无并发症的感染,如膀胱炎,也能引起更严重的后果,包括肾盂肾炎,在某些情况下还会导致肾功能衰竭。宿主通过尿流、尿路上皮脱落、细胞因子释放、抗菌肽和适应性免疫等机制防御感染。尽管医疗保健取得了进步,但尿路感染的负担仍然很高,因此需要继续研究其发病机制和预防。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medicine and Life
Journal of Medicine and Life Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
202
期刊介绍: The Journal of Medicine and Life publishes peer-reviewed articles from various fields of medicine and life sciences, including original research, systematic reviews, special reports, case presentations, major medical breakthroughs and letters to the editor. The Journal focuses on current matters that lie at the intersection of biomedical science and clinical practice and strives to present this information to inform health care delivery and improve patient outcomes. Papers addressing topics such as neuroprotection, neurorehabilitation, neuroplasticity, and neuroregeneration are particularly encouraged, as part of the Journal''s continuous interest in neuroscience research. The Editorial Board of the Journal of Medicine and Life is open to consider manuscripts from all levels of research and areas of biological sciences, including fundamental, experimental or clinical research and matters of public health. As part of our pledge to promote an educational and community-building environment, our issues feature sections designated to informing our readers regarding exciting international congresses, teaching courses and relevant institutional-level events.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信